Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectivity and Safety of Microwave Ablation Combined With Transcatheter Arterial Chemoembolization(TACE) for Huge Unresectable Hepatocellular Carcinoma: a Multicenter Analysis

NCT03277716 is registered in ClinicalTrials.gov with Fan Weijun as lead sponsor.

NCT NCT03277716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03277716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectivity and Safety of Microwave Ablation Combined With Transcatheter Arterial Chemoembolization(TACE) for Huge Unresectable Hepatocellular Carcinoma: a Multicenter Analysis
Lead sponsor
Fan Weijun
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2017
Completion date
December 30, 2021
Enrollment
100 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma non-resectable, microwave ablation, transarterial chemoembolization